Sector consensus Harvard Bioscience, Inc.
Stocks
HBIO
US4169062043
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
16:00:00 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 8.030 USD | -1.47% |
|
+0.12% | +20.07% |
| 08-11 | Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-11 | Harvard Bioscience, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 7.5 | -6.6% | 1 | ||||
| 645.15 | +5.79% | 27 | ||||||
| 229.09 | +14.46% | 23 | ||||||
| 476.34 | +29.04% | 29 | ||||||
| 62.41 | +45.22% | 29 | ||||||
| 45.52 | +19.07% | 19 | ||||||
| 100.96 | +19.67% | 26 | ||||||
| 174.95 | +19.07% | 21 | ||||||
| 442.71 | +8.42% | 24 | ||||||
| 246.44 | +12.9% | 16 | ||||||
| 202.65 | -1.84% | 20 | ||||||
| 229.51 | +41.04% | 17 | ||||||
| 82.5 | +29.05% | 18 | ||||||
| 26.9 | +27.22% | 20 | ||||||
| 126.12 | +1.45% | 17 | ||||||
| 2,161.54 | +9.72% | 13 | ||||||
| 59.23 | +10.86% | 13 | ||||||
| 121.8 | -3.33% | 5 | ||||||
| 9.983 | +44.06% | 6 | ||||||
| Average | 286.91 | +17.12% | 18 | ||||||
| Weighted average by Cap. | 358.12 | +17.70% | 24 |
- Stock Market
- Stocks
- HBIO Stock
- Sector Harvard Bioscience, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
